Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life

British Journal of Dermatology

Volumn 172, Issue 1, 2015, Pages 169-174

  Robinson, E S ^a,b   Feng, R ^b   Okawa, J ^a,b   Werth, V P ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS DERMATOMYOSITIS DISEASE AREA AND SEVERITY INDEX; DERMATOMYOSITIS; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; PAIN; PAIN ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; SELF EVALUATION; SENSITIVITY AND SPECIFICITY; VISUAL ANALOG SCALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

DERMATOMYOSITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PRURITUS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84920822898     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13167     Document Type: Article

References (16)

1. Drouet B, Le Loet X, Vittecoq O, et al,. A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis. Rev Rhum Engl Ed 1996; 63: 321-30.
2. Hundley JL, Carroll CL, Lang W, et al,. Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol 2006; 54: 217-20.
3. Goreshi R, Chock M, Foering K, et al,. Quality of life in dermatomyositis. J Am Acad Dermatol 2011; 65: 1107-16.
4. Klein RQ, Bangert CA, Costner M, et al,. Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol 2008; 159: 887-94.
5. Yassaee M, Fiorentino D, Okawa J, et al,. Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument. Br J Dermatol 2010; 162: 669-73.
6. Anyanwu CO, Fiorentino D, Chung L, et al,. Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing severity and assessing responsiveness to clinical change. Arthritis Rheumatol 2013; 65 (Suppl.): S824.
7. Chren MM, Lasek RJ, Quinn LM, et al,. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-13.
8. Chren MM, Lasek RJ, Quinn LM, Covinsky KE,. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997; 108: 103-7.
9. Harris PA, Taylor R, Thielke R, et al,. Research electronic data capture (REDcap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-81.
10. Piette EW, Foering KP, Chang AY, et al,. Impact of smoking in cutaneous lupus erythematosus. Arch Dermatol 2012; 148: 317-22.
11. Shirani Z, Kucenic MJ, Carroll CL, et al,. Pruritus in adult dermatomyositis. Clin Exp Dermatol 2004; 29: 273-6.
12. Lipsky PE, van der Heijde DM, St Clair EW, et al,. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000; 343: 1594-602.
13. Moreland LW, Schiff MH, Baumgartner SW, et al,. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999; 130: 478-86.
14. Chang AY, Ghazi E, Okawa J, Werth VP,. Quality of life differences between responders and nonresponders in the treatment of cutaneous lupus erythematosus. JAMA Dermatol 2013; 149: 104-6.
15. Boden JM, Fergusson DM, Horwood LJ,. Cigarette Smoking and depression: tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry 2010; 196: 440-6.
16. Taylor G, McNeill A, Girling A, et al,. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014; 348: g1151.